NCT02302768View on ClinicalTrials.gov

Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2015

Conditions
Thyroiditis Autoimmune
Interventions
DIETARY_SUPPLEMENT

Selenomethionine

OTHER

Placebo

Sponsors
All Listed Sponsors
collaborator

IBSA Institut Biochimique SA

INDUSTRY

lead

University of Siena

OTHER

NCT02302768 - Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT | Biotech Hunter | Biotech Hunter